Stage 3 Study On Injectable Male Contraceptive Halted Due To Side Effects.

In continuing coverage, the NPR (11/3) “Shots” blog and “All Things Considered” program report that a 320-participant, stage 3 trial testing a 96% effective injectable male contraceptive had to be halted “after an independent review panel found that the drug had too many side effects.” The findings were published last week in the Journal of Clinical Endocrinology and Metabolism. The fact that the study had to be halted due to severe depression and acne in participants is seen as a “setback and...a disappointment.” http://www.npr.org/sections/health-shots/2016/11/03/500549503/male-birth-control-study-killed-after-men-complain-about-side-effects